Central modulation of pain

Journal of Clinical Investigation

Volumn 120, Issue 11, 2010, Pages 3779-3787

  Ossipov, Michael H ^a   Dussor, Gregory O ^a   Porreca, Frank ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; BETA ENDORPHIN; CARFENTANIL; CHOLECYSTOKININ; CHOLECYSTOKININ B RECEPTOR; CLONIDINE; DERMORPHIN; DULOXETINE; DYNORPHIN; ENDOCANNABINOID; GABAPENTIN; GLYCINE; LIDOCAINE; MORPHINE; MU OPIATE RECEPTOR; MUSCIMOL; NALOXONE; NORADRENALIN; OPIATE; PLACEBO; PROSTAGLANDIN SYNTHASE INHIBITOR; SEROTONIN; SEROTONIN 3 RECEPTOR; SEROTONIN 7 RECEPTOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AMYGDALOID NUCLEUS; ANTINOCICEPTION; CELL ACTIVATION; CHRONIC PAIN; DRUG MECHANISM; FACILITATION; HUMAN; LOCUS CERULEUS; MEDULLA OBLONGATA; NEUROMODULATION; NEUROPATHIC PAIN; NOCICEPTIVE RECEPTOR; NOCICEPTIVE STIMULATION; NONHUMAN; NORADRENERGIC NERVE; PAIN; PAIN INHIBITION; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SEROTONINERGIC NERVE CELL; SPINAL GANGLION; STRESS; THALAMUS;

ANALGESICS; BRAIN; CHRONIC DISEASE; EMOTIONS; HUMANS; NEURAL PATHWAYS; NOCICEPTORS; NOREPINEPHRINE; PAIN; SEROTONIN; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL;

EID: 78049450440     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI43766     Document Type: Review

References (151)

1. Beecher HK. Pain in men wounded in battle. Ann Surg. 1946;123(1):96-105.
2. Bingel U, Tracey I. Imaging CNS modulation of pain in humans. Physiology (Bethesda). 2008;23(3):371-380.
3. Fields HL, Basbaum AI, Heinricher MM. Central nervous system mechanisms of pain modulation. In: McMahon S, Koltzenburg M, eds. Textbook of Pain. 5th ed. Burlington, Massachusetts, USA: Elsevier Health Sciences; 2005:125-142.
4. Beecher HK. The powerful placebo. J Am Med Assoc. 1955;159(17):1602-1606.
5. Levine JD, Gordon NC, Fields HL. The mechanism of placebo analgesia. Lancet. 1978;2(8091):654-657.
6. Petrovic P, Kalso E, Petersson KM, Ingvar M. Placebo and opioid analgesia - imaging a shared neuronal network. Science. 2002;295(5560):1737-1740.
7. Zubieta JK, et al. Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J Neurosci. 2005;25(34):7754-7762.
8. Tracey I, Mantyh PW. The cerebral signature for pain perception and its modulation. Neuron. 2007;55(3):377-391.
9. Eippert F, et al. Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron. 2009;63(4):533-543.
10. Tracey I, Johns E. The pain matrix: reloaded or reborn as we image tonic pain using arterial spin labelling. Pain. 2010;148(3):359-360.
11. Benedetti F, Lanotte M, Lopiano L, Colloca L. When words are painful: unraveling the mechanisms of the nocebo effect. NeuroScience. 2007;147(2):260-271.
12. Benedetti F, Pollo A, Lopiano L, Lanotte M, Vighetti S, Rainero I. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci. 2003;23(10):4315-4323.
13. Colloca L, Benedetti F. Nocebo hyperalgesia: how anxiety is turned into pain. Curr Opin Anaesthesiol. 2007;20(5):435-439.
14. Keltner JR, Furst A, Fan C, Redfern R, Inglis B, Fields HL. Isolating the modulatory effect of expectation on pain transmission: a functional magnetic resonance imaging study. J Neurosci. 2006;26(16):4437-4443.
15. Tsou K, Jang CS. Studies on the site of analgesic action of morphine by intracerebral micro-injection. Sci Sin. 1964;13:1099-1109.
16. Reynolds DV. Surgery in the rat during electrical analgesia induced by focal brain stimulation. Science. 1969;164(878):444-445.
17. Hosobuchi Y, Adams JE, Linchitz R. Pain relief by electrical stimulation of the central gray matter in humans and its reversal by naloxone. Science. 1977;197(4299):183-186.
18. Richardson DE, Akil H. Pain reduction by electrical brain stimulation in man. Part 1: Acute administration in periaqueductal and periventricular sites. J Neurosurg. 1977;47(2):178-183. (Pubitemid 8133080)
19. Richardson DE, Akil H. Long term results of periventricular gray self-stimulation. Neurosurgery. 1977;1(2):199-202.
20. Raskin NH, Hosobuchi Y, Lamb S. Headache may arise from perturbation of brain. Headache. 1987;27(8):416-420.
21. Richardson DE. Intracranial stimulation for the control of chronic pain. Clin Neurosurg. 1983;31:316-322.
22. Yeung JC, Yaksh TL, Rudy TA. Concurrent mapping of brain sites for sensitivity to the direct application of morphine and focal electrical stimulation in the production of antinociception in the rat. Pain. 1977;4(1):23-40.
23. Yaksh TL, Rudy TA. Narcotic analgestics: CNS sites and mechanisms of action as revealed by intracerebral injection techniques. Pain. 1978;4(4):299-359.
24. Lewis VA, Gebhart GF. Evaluation of the periaqueductal central gray (PAG) as a morphine-specific locus of action and examination of morphine-induced and stimulation-produced analgesia at coincident PAG loci. Brain Res. 1977;124(2):283-303.
25. Lewis VA, Gebhart GF. Morphine-induced and stimulation-produced analgesias at coincident periaqueductal central gray loci: evaluation of analgesic congruence, tolerance, and cross-tolerance. Exp Neurol. 1977;57(3):934-955.
26. Basbaum AI, Clanton CH, Fields HL. Opiate and stimulus-produced analgesia: functional anatomy of a medullospinal pathway. Proc Natl Acad Sci U S A. 1976;73(12):4685-4688.
27. Akil H, Mayer DJ, Liebeskind JC. Antagonism of stimulation-produced analgesia by naloxone, a narcotic antagonist. Science. 1976;191(4230):961-962.
28. Basbaum AI, Clanton CH, Fields HL. Three bulbospinal pathways from the rostral medulla of the cat: an autoradiographic study of pain modulating systems. J Comp Neurol. 1978;178(2):209-224.
29. Basbaum AI, Fields HL. Endogenous pain control mechanisms: review and hypothesis. Ann Neurol. 1978;4(5):451-462.
30. Basbaum AI, Fields HL. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci. 1984;7:309-338.
31. Bingel U, Schoell E, Buchel C. Imaging pain modulation in health and disease. Curr Opin Neurol. 2007;20(4):424-431.
32. Neugebauer V, Galhardo V, Maione S, Mackey SC. Forebrain pain mechanisms. Brain Res Rev. 2009;60(1):226-242.
33. Neugebauer V, Li W. Processing of nociceptive mechanical and thermal information in central amygdala neurons with knee-joint input. J Neurophysiol. 2002;87(1):103-112.
34. Neugebauer V, Li W. Differential sensitization of amygdala neurons to afferent inputs in a model of arthritic pain. J Neurophysiol. 2003;89(2):716-727.
35. Han JS, Neugebauer V. Synaptic plasticity in the amygdala in a visceral pain model in rats. Neurosci Lett. 2004;361(1-3):254-257.
36. Han JS, Bird GC, Neugebauer V. Enhanced group III mGluR-mediated inhibition of pain-related synaptic plasticity in the amygdala. Neuropharmacology. 2004;46(7):918-926.
37. Li W, Neugebauer V. Differential roles of mGluR1 and mGluR5 in brief and prolonged nociceptive processing in central amygdala neurons. J Neurophysiol. 2004;91(1):13-24.
38. Ji G, Fu Y, Ruppert KA, Neugebauer V. Pain-related anxiety-like behavior requires CRF1 receptors in the amygdala. Mol Pain. 2007;3:13.
39. Ji G, Neugebauer V. Hemispheric lateralization of pain processing by amygdala neurons. J Neurophysiol. 2009;102(4):2253-2264.
40. Carrasquillo Y, Gereau RWt. Hemispheric lateralization of a molecular signal for pain modulation in the amygdala. Mol Pain. 2008;4:24.
41. Fields HL, Anderson SD, Clanton CH, Basbaum AI. Nucleus raphe magnus: a common mediator of opiate- and stimulus- produced analgesia. Trans Am Neurol Assoc. 1976;101:208-210.
42. Sandkuhler J, Gebhart GF. Relative contributions of the nucleus raphe magnus and adjacent medullary reticular formation to the inhibition by stimulation in the periaqueductal gray of a spinal nociceptive reflex in the pentobarbital- anesthetized rat. Brain Res. 1984;305(1):77-87.
43. Abols IA, Basbaum AI. Afferent connections of the rostral medulla of the cat: a neural substrate for midbrain-medullary interactions in the modulation of pain. J Comp Neurol. 1981;201(2):285-297.
44. Glazer EJ, Basbaum AI. Immunohistochemical localization of leucine-enkephalin in the spinal cord of the cat: enkephalin-containing marginal neurons and pain modulation. J Comp Neurol. 1981;196(3):377-389.
45. Basbaum AI. Descending control of pain transmission: possible serotonergic-enkephalinergic interactions. Adv Exp Med Biol. 1981;133:177-189.
46. Anderson SD, Basbaum AI, Fields HL. Response of medullary raphe neurons to peripheral stimulation and to systemic opiates. Brain Res. 1977;123(2):363-368.
47. Fields HL, Basbaum AI, Clanton CH, Anderson SD. Nucleus raphe magnus inhibition of spinal cord dorsal horn neurons. Brain Res. 1977;126(3):441-453.
48. Heinricher MM, Barbaro NM, Fields HL. Putative nociceptive modulating neurons in the rostral ventromedial medulla of the rat: firing of on- and off-cells is related to nociceptive responsiveness. Somatosens Mot Res. 1989;6(4):427-439.
49. Potrebic SB, Mason P, Fields HL. The density and distribution of serotonergic appositions onto identified neurons in the rat rostral ventromedial medulla. J Neurosci. 1995;15(5 pt 1):3273-3283.
50. Fields HL, Bry J, Hentall I, Zorman G. The activity of neurons in the rostral medulla of the rat during withdrawal from noxious heat. J Neurosci. 1983;3(12):2545-2552.
51. Fields HL, Malick A, Burstein R. Dorsal horn projection targets of ON and OFF cells in the rostral ventromedial medulla. J Neurophysiol. 1995;74(4):1742-1759.
52. Vanegas H, Barbaro NM, Fields HL. Tail-Flick Related Activity in Medullospinal Neurons. Brain Research. 1984;321(1):135-141.
53. Urban MO, Gebhart GF. Supraspinal contributions to hyperalgesia. Proc Natl Acad Sci U S A. 1999;96(14):7687-7692.
54. Zhuo M, Gebhart GF. Characterization of descending facilitation and inhibition of spinal nociceptive transmission from the nuclei reticularis gigantocellularis and gigantocellularis pars alpha in the rat. J Neurophysiol. 1992;67(6):1599-1614.
55. Zhuo M, Gebhart GF. Biphasic modulation of spinal nociceptive transmission from the medullary raphe nuclei in the rat. J Neurophysiol. 1997;78(2):746-758.
56. Zhuo M, Gebhart GF. Facilitation and attenuation of a visceral nociceptive reflex from the rostroventral medulla in the rat. Gastroenterology. 2002;122(4):1007-1019. (Pubitemid 34267284)
57. Zhuo M, Gebhart GF. Characterization of descending inhibition and facilitation from the nuclei reticularis gigantocellularis and gigantocellularis pars alpha in the rat. Pain. 1990;42(3):337-350.
58. Morgan MM, Fields HL. Pronounced changes in the activity of nociceptive modulatory neurons in the rostral ventromedial medulla in response to prolonged thermal noxious stimuli. J Neurophysiol. 1994;72(3):1161-1170.
59. Kaplan H, Fields HL. Hyperalgesia during acute opioid abstinence: evidence for a nociceptive facilitating function of the rostral ventromedial medulla. J Neurosci. 1991;11(5):1433-1439.
60. Vanegas H, Schaible HG. Descending control of persistent pain: inhibitory or facilitatory? Brain Res Brain Res Rev. 2004;46(3):295-309.
61. Fang FG, Haws CM, Drasner K, Williamson A, Fields HL. Opioid peptides (DAGO-enkephalin, dynorphin A(1-13), BAM 22P) microinjected into the rat brainstem: comparison of their antinociceptive effect and their effect on neuronal firing in the rostral ventromedial medulla. Brain Res. 1989;501(1):116-128.
62. Jensen TS, Yaksh TL. Comparison of the antinociceptive effect of morphine and glutamate at coincidental sites in the periaqueductal gray and medial medulla in rats. Brain Res. 1989;476(1):1-9.
63. Cheng ZF, Fields HL, Heinricher MM. Morphine microinjected into the periaqueductal gray has differential effects on 3 classes of medullary neurons. Brain Res. 1986;375(1):57-65.
64. Heinricher MM, Morgan MM, Fields HL. Direct and indirect actions of morphine on medullary neurons that modulate nociception. NeuroScience. 1992;48(3):533-543.
65. Heinricher MM, Morgan MM, Tortorici V, Fields HL. Disinhibition of off-cells and antinociception produced by an opioid action within the rostral ventromedial medulla. NeuroScience. 1994;63(1):279-288.
66. Zhang W, et al. Neuropathic pain is maintained by brainstem neurons co-expressing opioid and cholecystokinin receptors. Brain. 2009;132(pt 3):778-787.
67. Winkler CW, Hermes SM, Chavkin CI, Drake CT, Morrison SF, Aicher SA. Kappa opioid receptor (KOR) and GAD67 immunoreactivity are found in OFF and NEUTRAL cells in the rostral ventromedial medulla. J Neurophysiol. 2006;96(6):3465-3473.
68. Oliveras JL, Hosobuchi Y, Guilbaud G, Besson JM. Analgesic electrical stimulation of the feline nucleus raphe magnus: development of tolerance and its reversal by 5-HTP. Brain Res. 1978;146(2):404-409.
69. Cui M, Feng Y, McAdoo DJ, Willis WD. Periaqueductal gray stimulation-induced inhibition of nociceptive dorsal horn neurons in rats is associated with the release of norepinephrine, serotonin, and amino acids. J Pharmacol Exp Ther. 1999;289(2):868-876.
70. Yaksh TL, Wilson PR. Spinal serotonin terminal system mediates antinociception. J Pharmacol Exp Ther. 1979;208(3):446-453.
71. Jensen TS, Yaksh TL. Spinal monoamine and opiate systems partly mediate the antinociceptive effects produced by glutamate at brainstem sites. Brain Res. 1984;321(2):287-297.
72. Kwiat GC, Basbaum AI. The origin of brainstem noradrenergic and serotonergic projections to the spinal cord dorsal horn in the rat. Somatosens Mot Res. 1992;9(2):157-173.
73. Potrebic SB, Fields HL, Mason P. Serotonin immunoreactivity is contained in one physiological cell class in the rat rostral ventromedial medulla. J Neurosci. 1994;14(3 pt 2):1655-1665.
74. Moore RY. The anatomy of central serotonin neuron systems in the rat brain. In: Jacobs BL, Gelperin A, eds. Serotonin Neurotransmission And Behavior. Cambridge, Massachusetts, USA: MIT Press; 1981:35-71.
75. Foo H, Mason P. Brainstem modulation of pain during sleep and waking. Sleep Med Rev. 2003;7(2):145-154.
76. Mason P. Contributions of the medullary raphe and ventromedial reticular region to pain modulation and other homeostatic functions. Annu Rev Neurosci. 2001;24:737-777.
77. Wei F, et al. Molecular depletion of descending serotonin unmasks its novel facilitatory role in the development of persistent pain. J Neurosci. 2010;30(25):8624-8636.
78. Suzuki R, Rygh LJ, Dickenson AH. Bad news from the brain: descending 5-HT pathways that control spinal pain processing. Trends Pharmacol Sci. 2004;25(12):613-617.
79. Dogrul A, Ossipov MH, Porreca F. Differential mediation of descending pain facilitation and inhibition by spinal 5HT-3 and 5HT-7 receptors. Brain Res. 2009;1280:52-59.
80. Sasaki M, Obata H, Kawahara K, Saito S, Goto F. Peripheral 5-HT2A receptor antagonism attenuates primary thermal hyperalgesia and secondary mechanical allodynia after thermal injury in rats. Pain. 2006;122(1-2):130-136.
81. Green GM, Scarth J, Dickenson A. An excitatory role for 5-HT in spinal inflammatory nociceptive transmission; state-dependent actions via dorsal horn 5-HT(3) receptors in the anaesthetized rat. Pain. 2000;89(1):81-88.
82. Rahman W, Bauer CS, Bannister K, Vonsy JL, Dolphin AC, Dickenson AH. Descending serotonergic facilitation and the antinociceptive effects of pregabalin in a rat model of osteoarthritic pain. Mol Pain. 2009;5:45.
83. Brenchat A, et al. 5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice. Pain. 2009;141(3):239-247.
84. Doly S, Fischer J, Brisorgueil MJ, Verge D, Conrath M. Pre- and postsynaptic localization of the 5-HT7 receptor in rat dorsal spinal cord: immunocytochemical evidence. J Comp Neurol. 2005;490(3):256-269.
85. Pierce PA, Xie GX, Levine JD, Peroutka SJ. 5-Hydroxytryptamine receptor subtype messenger RNAs in rat peripheral sensory and sympathetic ganglia: a polymerase chain reaction study. NeuroScience. 1996;70(2):553-559.
86. Hammond DL, Tyce GM, Yaksh TL. Efflux of 5-hydroxytryptamine and noradrenaline into spinal cord superfusates during stimulation of the rat medulla. J Physiol. 1985;359:151-162.
87. Barbaro NM, Hammond DL, Fields HL. Effects of intrathecally administered methysergide and yohimbine on microstimulation-produced antinociception in the rat. Brain Res. 1985;343(2):223-229.
88. Hammond DL, Yaksh TL. Antagonism of stimulation-produced antinociception by intrathecal administration of methysergide or phentolamine. Brain Res. 1984;298(2):329-337.
89. Bajic D, Proudfit HK. Projections of neurons in the periaqueductal gray to pontine and medullary cate-cholamine cell groups involved in the modulation of nociception. J Comp Neurol. 1999;405(3):359-379.
90. Holden JE, Proudfit HK. Enkephalin neurons that project to the A7 catecholamine cell group are located in nuclei that modulate nociception: ventromedial medulla. NeuroScience. 1998;83(3):929-947.
91. Yeomans DC, Proudfit HK. Projections of substance P-immunoreactive neurons located in the ventromedial medulla to the A7 noradrenergic nucleus of the rat demonstrated using retrograde tracing combined with immunocytochemistry. Brain Research. 1990;532(1-2):329-332.
92. Proudfit H. The behavioural pharmacology of the noradrenergic system. In: Guilbaud G, ed. Towards The Use Of Noradrenergic Agonists For The Treatment Of Pain. Amsterdam, Nederland: Elsevier; 1992:119-136.
93. Pertovaara A. Noradrenergic pain modulation. Prog Neurobiol. 2006;80(2):53-83.
94. Ossipov MH, Harris S, Lloyd P, Messineo E. An isobolographic analysis of the antinociceptive effect of systemically and intrathecally administered combinations of clonidine and opiates. J Pharmacol Exp Ther. 1990;255(3):1107-1116.
95. Ossipov MH, Harris S, Lloyd P, Messineo E, Lin BS, Bagley J. Antinociceptive interaction between opioids and medetomidine: systemic additivity and spinal synergy. Anesthesiology. 1990;73(6):1227-1235.
96. Eisenach JC, Hood DD, Curry R. Intrathecal, but not intravenous, clonidine reduces experimental thermal or capsaicin-induced pain and hyperalgesia in normal volunteers. Anesth Analg. 1998;87(3):591-596.
97. Budai D, Harasawa I, Fields HL. Midbrain periaqueductal gray (PAG) inhibits nociceptive inputs to sacral dorsal horn nociceptive neurons through alpha2-adrenergic receptors. J Neurophysiol. 1998;80(5):2244-2254.
98. Gassner M, Ruscheweyh R, Sandkuhler J. Direct excitation of spinal GABAergic interneurons by noradrenaline. Pain. 2009;145(1-2):204-210.
99. Watkins LR, Mayer DJ. Organization of endogenous opiate and nonopiate pain control systems. Science. 1982;216(4551):1185-1192.
100. Friederich MW, Walker JM. The effect of footshock on the noxious-evoked activity of neurons in the rostral ventral medulla. Brain Res Bull. 1990;24(4):605-608.
101. Nakagawasai O, et al. Changes in beta-endorphin and stress-induced analgesia in mice after exposure to forced walking stress. Methods Find Exp Clin Pharmacol. 1999;21(7):471-476.
102. Wiedenmayer CP, Barr GA. Mu opioid receptors in the ventrolateral periaqueductal gray mediate stress-induced analgesia but not immobility in rat pups. Behav Neurosci. 2000;114(1):125-136.
103. Foo H, Helmstetter FJ. Hypoalgesia elicited by a conditioned stimulus is blocked by a mu, but not a delta or a kappa, opioid antagonist injected into the rostral ventromedial medulla. Pain. 1999;83(3):427-431.
104. Bellgowan PS, Helmstetter FJ. The role of mu and kappa opioid receptors within the periaqueductal gray in the expression of conditional hypoalgesia. Brain Res. 1998;791(1-2):83-89.
105. Helmstetter FJ, Tershner SA, Poore LH, Bellgowan PS. Antinociception following opioid stimulation of the basolateral amygdala is expressed through the periaqueductal gray and rostral ventromedial medulla. Brain Res. 1998;779(1-2):104-118.
106. Hopkins E, Spinella M, Pavlovic ZW, Bodnar RJ. Alterations in swim stress-induced analgesia and hypothermia following serotonergic or NMDA antagonists in the rostral ventromedial medulla of rats. Physiol Behav. 1998;64(3):219-225.
107. Meng ID, Manning BH, Martin WJ, Fields HL. An analgesia circuit activated by cannabinoids. Nature. 1998;395(6700):381-383.
108. Hohmann AG, et al. An endocannabinoid mechanism for stress-induced analgesia. Nature. 2005;435(7045):1108-1112.
109. Suplita RL 2nd, Farthing JN, Gutierrez T, Hohmann AG. Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla. Neuropharmacology. 2005;49(8):1201-1209.
110. Pertovaara A, Wei H, Hamalainen MM. Lidocaine in the rostroventromedial medulla and the periaqueductal gray attenuates allodynia in neuropathic rats. Neuroscience Letters. 1996;218(2):127-130.
111. Burgess SE, et al. Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain. J Neurosci. 2002;22(12):5129-5136.
112. Kovelowski CJ, Ossipov MH, Sun H, Lai J, Malan TP, Porreca F. Supraspinal cholecystokinin may drive tonic descending facilitation mechanisms to maintain neuropathic pain in the rat. Pain. 2000;87(3):265-273.
113. Ossipov MH, Hong Sun T, Malan P Jr, Lai J, Porreca F. Mediation of spinal nerve injury induced tactile allodynia by descending facilitatory pathways in the dorsolateral funiculus in rats. Neurosci Lett. 2000;290(2):129-132.
114. Xie JY, et al. Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance. J Neurosci. 2005;25(2):409-416.
115. Heinricher MM, Neubert MJ. Neural basis for the hyperalgesic action of cholecystokinin in the rostral ventromedial medulla. J Neurophysiol. 2004;92(4):1982-1989.
116. Porreca F, et al. Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor. J Neurosci. 2001;21(14):5281-5288.
117. King T, et al. Unmasking the tonic-aversive state in neuropathic pain. Nat Neurosci. 2009;12(11):1364-1366.
118. Gardell LR, et al. Mouse strains that lack spinal dynorphin upregulation after peripheral nerve injury do not develop neuropathic pain. NeuroScience. 2004;123(1):43-52.
119. Gardell LR, et al. Enhanced evoked excitatory transmitter release in experimental neuropathy requires descending facilitation. J Neurosci. 2003;23(23):8370-8379.
120. Lai J, et al. Dynorphin A activates bradykinin receptors to maintain neuropathic pain. Nat Neurosci. 2006;9(12):1534-1540.
121. Wang H, et al. Bradykinin produces pain hypersensitivity by potentiating spinal cord glutamatergic synaptic transmission. J Neurosci. 2005;25(35):7986-7992.
122. Chen Q, Vera-Portocarrero LP, Ossipov MH, Vardanyan M, Lai J, Porreca F. Attenuation of persistent experimental pancreatitis pain by a bradykinin b2 receptor antagonist [published online ahead of print June 5, 2010]. Pancreas. doi:10.1097/MPA.0b013e3181df1c90.
123. Lai J, Luo MC, Chen Q, Porreca F. Pronociceptive actions of dynorphin via bradykinin receptors. Neurosci Lett. 2008;437(3):175-179.
124. Le Bars D, Dickenson AH, Besson JM. Diffuse noxious inhibitory controls (DNIC). II. Lack of effect on non-convergent neurones, supraspinal involvement and theoretical implications. Pain. 1979;6(3):305-327.
125. Le Bars D, Dickenson AH, Besson JM. Diffuse noxious inhibitory controls (DNIC). I. Effects on dorsal horn convergent neurones in the rat. Pain. 1979;6(3):283-304.
126. Le Bars D, Chitour D, Kraus E, Dickenson AH, Besson JM. Effect of naloxone upon diffuse noxious inhibitory controls (DNIC) in the rat. Brain Res. 1981;204(2):387-402. (Pubitemid 11205709)
127. Kraus E, Le Bars D, Besson JM. Behavioral confirmation of "diffuse noxious inhibitory controls" (DNIC) and evidence for a role of endogenous opiates. Brain Res. 1981;206(2):495-499. (Pubitemid 11170234)
128. Le Bars D, et al. [Are bulbo-spinal serotonergic systems involved in the detection of nociceptive messages? (author's transl)]. J Physiol (Paris). 1981;77(2-3):463-471.
129. Morton CR, Maisch B, Zimmermann M. Diffuse noxious inhibitory controls of lumbar spinal neurons involve a supraspinal loop in the cat. Brain Res. 1987;410(2):347-352.
130. Villanueva L, Le Bars D. The activation of bulbospinal controls by peripheral nociceptive inputs: diffuse noxious inhibitory controls. Biol Res. 1995;28(1):113-125.
131. Leite-Almeida H, Valle-Fernandes A, Almeida A. Brain projections from the medullary dorsal reticular nucleus: an anterograde and retrograde tracing study in the rat. NeuroScience. 2006;140(2):577-595.
132. Lima D, Almeida A. The medullary dorsal reticular nucleus as a pronociceptive centre of the pain control system. Prog Neurobiol. 2002;66(2):81-108.
133. Almeida A, Tavares I, Lima D, Coimbra A. Descending projections from the medullary dorsal reticular nucleus make synaptic contacts with spinal cord lamina I cells projecting to that nucleus: an electron microscopic tracer study in the rat. NeuroScience. 1993;55(4):1093-1106. (Pubitemid 23231919)
134. Monconduit L, Desbois C, Villanueva L. The integrative role of the rat medullary subnucleus reticularis dorsalis in nociception. Eur J Neurosci. 2002;16(5):937-944. (Pubitemid 35463585)
135. Le Bars D. The whole body receptive field of dorsal horn multireceptive neurones. Brain Res Brain Res Rev. 2002;40(1-3):29-44. (Pubitemid 36183156)
136. Villanueva L. Diffuse Noxious Inhibitory Control (DNIC) as a tool for exploring dysfunction of endogenous pain modulatory systems. Pain. 2009;143(3):161-162.
137. King CD, Wong F, Currie T, Mauderli AP, Fillingim RB, Riley JL 3rd. Deficiency in endogenous modulation of prolonged heat pain in patients with Irritable Bowel Syndrome and Temporomandibular Disorder. Pain. 2009;143(3):172-178.
138. Arendt-Nielsen L, et al. Sensitization in patients with painful knee osteoarthritis. Pain. 2010;149(3):573-581.
139. Olesen SS, et al. Descending inhibitory pain modulation is impaired in patients with chronic pancreatitis. Clin Gastroenterol Hepatol. 2010;8(8):724-730.
140. Leffler AS, Kosek E, Lerndal T, Nordmark B, Hansson P. Somatosensory perception and function of diffuse noxious inhibitory controls (DNIC) in patients suffering from rheumatoid arthritis. Eur J Pain. 2002;6(2):161-176.
141. Leffler AS, Hansson P, Kosek E. Somatosensory perception in a remote pain-free area and function of diffuse noxious inhibitory controls (DNIC) in patients suffering from long-term trapezius myalgia. Eur J Pain. 2002;6(2):149-159.
142. Pielsticker A, Haag G, Zaudig M, Lautenbacher S. Impairment of pain inhibition in chronic tension-type headache. Pain. 2005;118(1-2):215-223.
143. Cathcart S, Winefield AH, Lushington K, Rolan P. Noxious inhibition of temporal summation is impaired in chronic tension-type headache. Headache. 2009;50(3):403-412.
144. Okada-Ogawa A, Porreca F, Meng ID. Sustained morphine-induced sensitization and loss of diffuse noxious inhibitory controls in dura-sensitive medullary dorsal horn neurons. J Neurosci. 2009;29(50):15828-15835.
145. Landau R, et al. An experimental paradigm for the prediction of Post-Operative Pain (PPOP). J Vis Exp. 2010;(35). pii: 1671. doi:10.3791/1671.
146. Yarnitsky D, et al. Prediction of chronic post-operative pain: pre-operative DNIC testing identifies patients at risk. Pain. 2008;138(1):22-28.
147. Fairbanks CA, Kitto KF, Nguyen HO, Stone LS, Wilcox GL. Clonidine and dexmedetomidine produce antinociceptive synergy in mouse spinal cord. Anesthesiology. 2009;110(3):638-647.
148. Maizels M, McCarberg B. Antidepressants and antiepileptic drugs for chronic non-cancer pain. Am Fam Physician. 2005;71(3):483-490.
149. Hayashida K, DeGoes S, Curry R, Eisenach JC. Gabapentin activates spinal noradrenergic activity in rats and humans and reduces hypersensitivity after surgery. Anesthesiology. 2007;106(3):557-562.
150. Conroy JL, et al. Opioids activate brain analgesic circuits through cytochrome P450/epoxygenase signaling. Nat Neurosci. 2010;13(3):284-286.
151. Jasmin L, et al. The NK1 receptor mediates both the hyperalgesia and the resistance to morphine in mice lacking noradrenaline. Proc Natl Acad Sci U S A. 2002;99(2):1029-1034.